Article info
PDFEHDN Plenary Meeting: abstracts
Experimental therapeutics: preclinical
B06 Validation of KMO as a candidate therapeutic target for Huntington's disease in Drosophila melanogaster
Citation
B06 Validation of KMO as a candidate therapeutic target for Huntington's disease in Drosophila melanogaster
Publication history
- First published November 16, 2010.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.